| 产品描述: | 强大的腺苷激酶抑制剂;Potent, adenosine kinase inhibitor;5-Iodotubercidin(NSC 113939; 5-ITu) is a potent adenosine kinase inhibitor (IC50 = 26 nM).;5-Iodotubercidin(NSC 113939; 5-ITu) is a potent adenosine kinase inhibitor (IC50 = 26 nM).A potent and competitive inhibitor of ERK2, PKA, and ADK. |
| 靶点: |
IC50: 26 nM (adenosine kinase) |
| 体内研究: |
5-Iodotubercidin (1 mL/kg,腹腔注射) 与观察到的 AKI 局部给药至前驱皮质后针对荷包牡丹碱诱导的癫痫发作的活性一致。 |
| 参考文献: |
1. Massillon D, et al. Identification of the glycogenic compound 5-iodotubercidin as a general protein kinase inhibitor. Biochem J. 1994 Apr 1;299 (Pt 1):123-8. 2. Ugarkar BG, et al. Adenosine kinase inhibitors. 1. Synthesis, enzyme inhibition, and antiseizure activity of 5-iodotubercidin analogues. J Med Chem. 2000 Jul 27;43(15):2883-93. 3. García-Villafranca J, et al. Effects of 5-iodotubercidin on hepatic fatty acid metabolism mediated by the inhibition of acetyl-CoA carboxylase. Biochem Pharmacol. 2002 Jun 1;63(11):1997-2000. 4. De Antoni A, et al. A small-molecule inhibitor of Haspin alters the kinetochore functions of Aurora B. J Cell Biol. 2012 Oct 15;199(2):269-84. 5. Acharya MM, et al. Adenosine Kinase Inhibition Protects against Cranial Radiation-Induced Cognitive Dysfunction. Front Mol Neurosci. 2016 Jun 3;9:42. |
| 保存条件: |
避光,-80℃(运输条件:冰袋低温运输) |
| 配置溶液浓度参考: |
|
1mg |
5mg |
10mg |
| 1 mM |
2.55 ml |
12.75 ml |
25.5 ml |
| 5 mM |
0.51 ml |
2.55 ml |
5.1 ml |
| 10 mM |
0.255 ml |
1.275 ml |
2.55 ml |
| 50 mM |
0.051 ml |
0.255 ml |
0.51 ml |
|
| 注意: |
部分产品我司仅能提供部分信息,我司不保证所提供信息的权威性,仅供客户参考交流研究之用。 |